Sol-Gel Technologies (SLGL) Shareholder's Equity (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Sol-Gel Technologies | 205.76 Mn | 194.73 Mn | - | 22.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.81 Mn |
| Sep 30, 2025 | 26.03 Mn |
| Jun 30, 2025 | 31.88 Mn |
| Mar 31, 2025 | 20.17 Mn |
| Dec 31, 2024 | 28.85 Mn |
| Sep 30, 2024 | 34.71 Mn |
| Jun 30, 2024 | 34.90 Mn |
| Mar 31, 2024 | 32.65 Mn |
| Dec 31, 2023 | 38.64 Mn |
| Sep 30, 2023 | 43.13 Mn |
| Jun 30, 2023 | 48.30 Mn |
| Mar 31, 2023 | 44.06 Mn |
| Dec 31, 2022 | 42.21 Mn |
| Sep 30, 2022 | 47.47 Mn |
| Jun 30, 2022 | 50.35 Mn |
| Mar 31, 2022 | 50.12 Mn |
| Dec 31, 2021 | 55.59 Mn |
| Sep 30, 2021 | 41.44 Mn |
| Jun 30, 2021 | 39.25 Mn |
| Mar 31, 2021 | 47.06 Mn |
| Dec 31, 2020 | 50.85 Mn |
| Sep 30, 2020 | 57.16 Mn |
| Jun 30, 2020 | 65.52 Mn |
| Mar 31, 2020 | 67.13 Mn |
| Dec 31, 2019 | 52.47 Mn |
| Sep 30, 2019 | 58.57 Mn |
| Jun 30, 2019 | 54.74 Mn |
| Mar 31, 2019 | 58.97 Mn |
| Dec 31, 2018 | 63.91 Mn |
| Dec 31, 2017 | -52.70 Mn |
| Dec 31, 2016 | -31.34 Mn |